4.6 Article

Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Motor Progression and Nigrostriatal Neurodegeneration in Parkinson Disease

Koji Furukawa et al.

Summary: This study investigates the correlation between motor impairments and striatal dopaminergic terminal degeneration and nigral neuromelanin-laden dopamine neuron loss in different stages of Parkinson's disease. The findings suggest that striatal dopaminergic terminal loss is a biomarker for early stage motor impairments, while nigral dopamine neuron loss is a biomarker for advanced stage motor impairments.

ANNALS OF NEUROLOGY (2022)

Review Neurosciences

T Lymphocytes in Parkinson's Disease

Elena Contaldi et al.

Summary: This review discusses the involvement of T cells in Parkinson's disease, highlighting their roles in both the central and peripheral nervous system, their significance as biomarkers of disease progression, and recent therapeutic strategies targeting T cell response.

JOURNAL OF PARKINSONS DISEASE (2022)

Review Immunology

Inflammation and immune dysfunction in Parkinson disease

Malu Gamez Tansey et al.

Summary: This review explores the role of an ageing immune system, host genetics, and exposure to environmental stressors in promoting the development of Parkinson's disease. It discusses the presence of neuroinflammation and alterations in immune cell populations as well as the potential contributions of viral or bacterial exposure, pesticides, and gut microbiota to disease pathogenesis.

NATURE REVIEWS IMMUNOLOGY (2022)

Review Clinical Neurology

Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease

Etienne C. Hirsch et al.

Summary: Parkinson's disease is a progressive and debilitating disorder with neuroinflammation playing a role in its pathophysiology. Research into the neuroinflammatory processes of Parkinson's disease is ongoing, with many unanswered questions still remaining to be explored for the development of effective treatments.

MOVEMENT DISORDERS (2021)

Article Clinical Neurology

Peripheral inflammation exacerbates α-synuclein toxicity and neuropathology in Parkinson's models

P. La Vitola et al.

Summary: The study demonstrates that peripherally induced neuroinflammation can potentiate the detrimental effects of alpha-synuclein oligomers and worsen cognitive deficits in A53T mice. Fine management of neuroinflammation may offer a promising therapeutic approach to prevent or slow down some behavioral aspects in alpha-synucleinopathies.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2021)

Article Clinical Neurology

Lower Lymphocyte Count is Associated With Increased Risk of Parkinson's Disease

Melanie P. Jensen et al.

Summary: Lower lymphocyte count is associated with an increased risk of subsequent Parkinson's disease. Other blood markers, such as reductions in eosinophil counts, monocyte counts, and C-reactive protein, may also be related to increased disease risk, but only the association with lower lymphocyte count remains robust. Mendelian randomization analysis suggests a potential causal relationship between lower lymphocyte count and Parkinson's disease risk.

ANNALS OF NEUROLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Levodopa-Induced Dyskinesia in Parkinson Disease Specifically Associates With Dopaminergic Depletion in Sensorimotor-Related Functional Subregions of the Striatum

Miguel A. Labrador-Espinosa et al.

Summary: The study found that reductions in DAT levels in the sensorimotor striatal subregion were most pronounced in PD patients who developed LID, providing a potentially sensitive tool for early detection and improved prognosis of this common complication in PD.

CLINICAL NUCLEAR MEDICINE (2021)

Review Medicine, General & Internal

Parkinson's disease

Bastiaan R. Bloem et al.

Summary: Parkinson's disease is a neurodegenerative condition with diverse causes and clinical presentations. Diagnosis is clinically based, and treatment goals vary from person to person, emphasizing the need for personalized management. Currently, there is no therapy to slow down or arrest the progression of Parkinson's disease.

LANCET (2021)

Article Clinical Neurology

Relationship between 123I-FP-CIT-SPECT and motor severity in drug-naive patients with Parkinson's disease

Hiroo Terashi et al.

Summary: The results of this study showed that I-123-FP-CIT-SPECT findings were significantly associated with motor severity and gait severity in drug-naive patients with Parkinson's disease (PD), particularly the mean specific binding ratios of the striatum and anterior putamen.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2021)

Article Clinical Neurology

Peripheral Immune Profile and Neutrophil-to-Lymphocyte Ratio in Parkinson's Disease

Laura Munoz-Delgado et al.

Summary: Parkinson's disease patients exhibit altered peripheral immune profiles and higher neutrophil-to-lymphocyte ratio (NLR) compared to healthy controls. However, there appears to be no significant association between NLR and clinical characteristics of Parkinson's disease. A meta-analysis also suggests higher NLR in Parkinson's disease patients.

MOVEMENT DISORDERS (2021)

Article Clinical Neurology

Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson Disease

Zhaoqi Yan et al.

Summary: The study reveals alterations in CD4(+) T cells and B cells in patients with early-stage Parkinson's disease, showing a proinflammatory state and associations with clinical motor disease severity.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)

Article Clinical Neurology

Blood biomarkers with Parkinson's disease clusters and prognosis: the oxford discovery cohort

Michael Lawton et al.

MOVEMENT DISORDERS (2020)

Review Clinical Neurology

Parkinson disease and the immune system - associations, mechanisms and therapeutics

Eng-King Tan et al.

NATURE REVIEWS NEUROLOGY (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

MRI-guided voxel-based automatic semi-quantification of dopamine transporter imaging

Jiri Trnka et al.

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2020)

Review Clinical Neurology

Peripheral-Central Neuroimmune Crosstalk in Parkinson's Disease: What Do Patients and Animal Models Tell Us?

Marie Therese Fuzzati-Armentero et al.

FRONTIERS IN NEUROLOGY (2019)

Review Neurosciences

Immune system responses in Parkinson's disease: Early and dynamic

Malu G. Tansey et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Semiquantitative Analysis of Dopamine Transporter Scans in Patients With Parkinson Disease

Sule Tinaz et al.

CLINICAL NUCLEAR MEDICINE (2018)

Review Neurosciences

The role of T cells in the pathogenesis of Parkinson's disease

Zhichun Chen et al.

PROGRESS IN NEUROBIOLOGY (2018)

Review Neurosciences

Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts

Usman Saeed et al.

TRANSLATIONAL NEURODEGENERATION (2017)

Review Clinical Neurology

MDS clinical diagnostic criteria for Parkinson's disease

Ronald B. Postuma et al.

MOVEMENT DISORDERS (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

Elaboration of the SPM template for the standardization of SPECT images with 123I-Ioflupane

F. J. Garcia-Gomez et al.

REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR (2013)

Review Neurosciences

The Parkinson Progression Marker Initiative (PPMI)

Kenneth Marek et al.

PROGRESS IN NEUROBIOLOGY (2011)

Review Immunology

The immunoregulatory role of dopamine: An update

Chandrani Sarkar et al.

BRAIN BEHAVIOR AND IMMUNITY (2010)

Review Clinical Neurology

Circuits and circuit disorders of the basal ganglia

Mahlon R. DeLong et al.

ARCHIVES OF NEUROLOGY (2007)